Clinical Gastroenterology and Hepatology
Volume 7, Issue 9 , Pages 960-965 , September 2009

A Population-Based Study Showing an Association Between Gastroesophageal Reflux Disease and Sleep Problems

  • Catarina Jansson

      Affiliations

    • Unit of Esophageal and Gastric Research (ESOGAR), Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    • Corresponding Author InformationReprint requests Address requests for reprints to: Catarina Jansson, PhD, Unit of Esophageal and Gastric Research, P9:03, Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-171 76 Stockholm, Sweden. fax: (46) 8-33-15-87
    • ,
  • Helena Nordenstedt

      Affiliations

    • Unit of Esophageal and Gastric Research (ESOGAR), Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Mari–Ann Wallander

      Affiliations

    • AstraZeneca R & D, Mölndal, Sweden
    • Department of Public Health and Caring Science, Uppsala University, Uppsala, Sweden
    • ,
  • Saga Johansson

      Affiliations

    • AstraZeneca R & D, Mölndal, Sweden
    • Institute of Medicine, Sahlgrenska Academy, Göteborg University, Göteborg, Sweden
    • ,
  • Roar Johnsen

      Affiliations

    • Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway
    • HUNT Research Centre, Verdal, Norway
    • ,
  • Kristian Hveem

      Affiliations

    • HUNT Research Centre, Verdal, Norway
    • ,
  • Jesper Lagergren

      Affiliations

    • Unit of Esophageal and Gastric Research (ESOGAR), Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

References 

  1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920quiz 1943.
  2. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–208
  3. Liuzzo JP, Ambrose JA. Chest pain from gastroesophageal reflux disease in patients with coronary artery disease. Cardiol Rev. 2005;13:167–173
  4. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5:17–26
  5. Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994;69:539–547
  6. Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–717
  7. Dubois RW, Aguilar D, Fass R, et al. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity. Aliment Pharmacol Ther. 2007;25:487–500
  8. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis. 2004;22:108–114
  9. Ronkainen J, Aro P, Storskrubb T, et al. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population: the Kalixanda study. Aliment Pharmacol Ther. 2006;23:1725–1733
  10. Chow WH, Finkle WD, McLaughlin JK, et al. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA. 1995;274:474–477
  11. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831
  12. Dean BB, Crawley JA, Schmitt CM, et al. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther. 2003;17:1309–1317
  13. In:  Nordenstedt H editors. Gastroesophageal reflux: etiological factors. Stockholm: Karolinska Institutet, Department of Molecular Medicine and Surgery; 2007;
  14. Jaspersen D, Kulig M, Labenz J, et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther. 2003;17:1515–1520
  15. Lagergren J. Body measures in relation to gastro-oesophageal reflux. Gut. 2007;56:741–742
  16. Ruigomez A, Garcia Rodriguez LA, Wallander MA, et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther. 2004;20:751–760
  17. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101:2619–2628
  18. Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290:66–72
  19. Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354:2340–2348
  20. Nilsson M, Johnsen R, Ye W, et al. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut. 2004;53:1730–1735
  21. Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux: a population-based study. Aliment Pharmacol Ther. 2006;23:169–174
  22. Zheng Z, Nordenstedt H, Pedersen NL, et al. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology. 2007;132:87–95
  23. Cameron AJ, Lagergren J, Henriksson C, et al. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology. 2002;122:55–59
  24. Mohammed I, Cherkas LF, Riley SA, et al. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut. 2003;52:1085–1089
  25. Nordenstedt H, Nilsson M, Johansson S, et al. The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trondelag health survey. Chest. 2006;129:1051–1056
  26. Jansson C, Nordenstedt H, Wallander MA, et al. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther. 2007;26:683–691
  27. Jansson C, Nordenstedt H, Wallander MA, et al. Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population-based study. Aliment Pharmacol Ther. 2008;27:58–65
  28. Jansson C, Nordenstedt H, Johansson S, et al. Relation between gastroesophageal reflux symptoms and socioeconomic factors: a population-based study (the HUNT Study). Clin Gastroenterol Hepatol. 2007;5:1029–1034
  29. Hajak G. Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci. 2001;251:49–56
  30. Sivertsen B, Overland S, Neckelmann D, et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol. 2006;163:1018–1024
  31. Wallander MA, Johansson S, Ruigomez A, et al. Morbidity associated with sleep disorders in primary care: a longitudinal cohort study. Prim Care Companion J Clin Psychiatry. 2007;9:338–345
  32. Zee PC, Turek FW. Sleep and health: everywhere and in both directions. Arch Intern Med. 2006;166:1686–1688
  33. Akerstedt T. Psychosocial stress and impaired sleep. Scand J Work Environ Health. 2006;32:493–501
  34. Orr WC. Reflux events and sleep: are we vulnerable?. Curr Gastroenterol Rep. 2006;8:202–207
  35. Shaker R, Castell DO, Schoenfeld PS, et al. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol. 2003;98:1487–1493
  36. Malfertheiner P, Hallerback B. Clinical manifestations and complications of gastroesophageal reflux disease (GERD). Int J Clin Pract. 2005;59:346–355
  37. Krokstad S, Westin S. Health inequalities by socioeconomic status among men in the Nord-Trondelag Health Study, Norway. Scand J Public Health. 2002;30:113–124
  38. Breslow NE, Day NE. Statistical methods in cancer research: volume I—the analysis of case-control studies. IARC Sci Publ. 1980;5338
  39. SAS II. Changes and enhancements through release 6.11. Cary, NC: SAS Institute Inc; 1996;
  40. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:52–57
  41. Rothman K, Greenland S. Modern epidemiology. 2nd ed.. Philadelphia: Lippincott-Raven Publishers; 1998;
  42. Shaheen NJ, Madanick RD, Alattar M, et al. Gastroesophageal reflux disease as an etiology of sleep disturbance in subjects with insomnia and minimal reflux symptoms: a pilot study of prevalence and response to therapy. Dig Dis Sci. 2008;53:1493–1499
  43. Schey R, Dickman R, Parthasarathy S, et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology. 2007;133:1787–1795
  44. Lagergren J, Bergstrom R, Adami HO, et al. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000;133:165–175
  45. Corley DA, Levin TR, Habel LA, et al. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006;101:937–944
  46. Johnson DA, Orr WC, Crawley JA, et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol. 2005;100:1914–1922

 Conflicts of interest The authors disclose no conflicts.

 Funding This study was supported by AstraZeneca R&D, Mölndal, Sweden.

PII: S1542-3565(09)00214-6

doi: 10.1016/j.cgh.2009.03.007

Clinical Gastroenterology and Hepatology
Volume 7, Issue 9 , Pages 960-965 , September 2009